Compare NOM & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOM | NMTC |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 31.5M |
| IPO Year | N/A | N/A |
| Metric | NOM | NMTC |
|---|---|---|
| Price | $11.25 | $0.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | 6.9K | ★ 252.9K |
| Earning Date | 01-01-0001 | 12-17-2025 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 250.35 |
| 52 Week Low | $8.52 | $0.40 |
| 52 Week High | $10.48 | $1.39 |
| Indicator | NOM | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 57.16 |
| Support Level | $11.25 | $0.65 |
| Resistance Level | $11.58 | $0.83 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 69.86 | 71.13 |
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.